Literature DB >> 12813140

Tumor markers: from laboratory to clinical utility.

Anne-Sofie Schrohl1, Mads Holten-Andersen, Fred Sweep, Manfred Schmitt, Nadia Harbeck, John Foekens, Nils Brünner.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12813140     DOI： 10.1074/mcp.R300006-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN： 1535-9476            Impact factor:   5.911


× No keyword cloud information.
  20 in total

1.  Absolute quantitation of isoforms of post-translationally modified proteins in transgenic organism.

Authors:  Yaojun Li; Yiwei Shu; Changchao Peng; Lin Zhu; Guangyu Guo; Ning Li
Journal:  Mol Cell Proteomics       Date:  2012-03-22       Impact factor: 5.911

2.  Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness.

Authors:  D Arioli; M Pipino; E Boldrini; E Amateis; A Cristani; P Ventura; E Romagnoli; M C De Santis; M L Zeneroli
Journal:  Intern Emerg Med       Date:  2007-07-09       Impact factor: 3.397

3.  Combining results from lectin affinity chromatography and glycocapture approaches substantially improves the coverage of the glycoproteome.

Authors:  Claudia A McDonald; Jane Y Yang; Vinita Marathe; Ten-Yang Yen; Bruce A Macher
Journal:  Mol Cell Proteomics       Date:  2008-10-15       Impact factor: 5.911

4.  Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum.

Authors:  Aida Pitarch; César Nombela; Concha Gil
Journal:  Mol Cell Proteomics       Date:  2010-09-21       Impact factor: 5.911

Review 5.  Odontogenic tumor markers - an overview.

Authors:  B R Premalatha; Shankargouda Patil; Roopa S Rao; Narendranatha P Reddy; M Indu
Journal:  J Int Oral Health       Date:  2013-04

Review 6.  HER2/neu, Topoisomerase 2a, Estrogen and Progesterone Receptors: Discordance between Primary Breast Cancer and Metastatic Axillary Lymph Node in Expression and Amplification Characteristics.

Authors:  Beyhan Ataseven; Daniela Gologan; Angela Gunesch; Victoria Kehl; Bernhard Hoegel; Michaela Beer; Wolfgang Eiermann
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

7.  Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma.

Authors:  Zhi Wang; Lu Jiang; Canhua Huang; Zhengyu Li; Lijuan Chen; Lantu Gou; Ping Chen; Aiping Tong; Minghai Tang; Feng Gao; Jun Shen; Yuanyuan Zhang; Jingping Bai; Min Zhou; Di Miao; Qianming Chen
Journal:  Mol Cell Proteomics       Date:  2008-05-04       Impact factor: 5.911

8.  Methodology and applications of disease biomarker identification in human serum.

Authors:  Ziad J Sahab; Suzan M Semaan; Qing-Xiang Amy Sang
Journal:  Biomark Insights       Date:  2007-02-14

Review 9.  Clinical biomarkers in oncology: focus on colorectal cancer.

Authors:  Wendy De Roock; Bart Biesmans; Jef De Schutter; Sabine Tejpar
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 10.  Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing?

Authors:  Andrey Iskrenov Kotzev; Peter Vassilev Draganov
Journal:  Gastrointest Tumors       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.